The following is a statement on HIV Vaccine Awareness Day from Anthony Fauci, MD, Director of National Institute of Allergy and Infectious Diseases of the National Institutes of Health. It was originally published here. There is a growing consensus that we can significantly curtail the HIV/AIDS pandemic by implementing scientifically proven HIV prevention strategies, such as voluntary […]
The following guest blog post in honor of HIV Vaccine Awareness Day was written by Margaret McGlynn, IAVI President and CEO. It originally appeared on USAID’s Impact blog. Throughout my career, I have witnessed the tremendous power of vaccines to prevent sickness and save lives – delivering incredible victories for humanity against diseases such as polio, […]
The House Appropriations Committee voted on its fiscal year (FY) 2013 State and Foreign Operations Appropriations bill Wednesday and released a report that clarifies its funding intentions for key global health programs. The bill includes $5.542 billion for global AIDS funding through the State Department, and the report specifies $4.243 billion to support the U.S. […]
***UPDATE 12/19: The final spending bill for FY 2012 was agreed to by the Senate. The resolution to fund the emergency spending bill with an across the board 1.83 percent cut to most discretionary funds did not pass. Also of interest, The Centers for Disease Control and Prevention (CDC) domestic TB budget for FY 2012 […]
The U.S. military’s contributions to global health and the HIV response might not be well publicized, but advocates tried to change that Friday by hosting a Capitol Hill briefing touting the accomplishments of the Walter Reed Army Institute of Research (WRAIR) Military HIV Research Program (MHRP) – a $175 million program supported by the Department of Defense and other entities that is vulnerable to cuts in the fiscal year 2012 funding battle currently taking place on the Hill…
Speaking out against a potential $16 million cut for military HIV research proposed in the Senate version of the Department of Defense Appropriations bill for fiscal year (FY) 2012, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP).
The following is a guest blog post by Mitchell Warren, executive director of AVAC – Global Advocacy for HIV Prevention. Recent news about HIV/AIDS has focused on the good – promising trial results that prove the same antiretroviral (ARV) drugs used to treat HIV can also prevent HIV infections; and the bad – retreats in […]
In a new article published today in the journal Nature, a team of researchers reported the isolation of 17 novel antibodies capable of deactivating a broad spectrum of HIV variants – which could be huge in the development of an HIV vaccine.
The team of researchers hailed from the International AIDS Vaccine Initiative (IAVI), the Scripps Research Institute, Theraclone Sciences and Monogram Biosciences Inc.
Science Speaks interviewed one of the paper’s co-authors, Wayne C. Koff, PhD, on this exciting new science to get a better grasp on the thinking behind broadly neutralizing antibodies (bNAbs) and the AIDS vaccine development process.
The U.S. Department of Defense might not incite thoughts of contributions to global health, but a briefing Thursday on Capitol Hill shed new light on that thinking.
“The Walter Reed Army Institute of Research (WRAIR) is one of the largest developers of vaccines in the non-private sector,” said Peter Hotez, MD, PhD…
At a recent briefing on Capitol Hill entitled, “Making the Case for Cost-Effectiveness of Vaccines for Global Health,” Peter Hotez, MD, PhD, President of the Sabin Vaccine Institute, talked about a little-known infection called schistosomiasis. A disease caused by parasitic worms, Hotez called it “the most important cause of HIV you’ve never heard of.” Moving […]